Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor + aspirin vs placebo + aspirin in acute ischemic stroke or high-risk TIA
CTR20180172Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, transient ischaemic attack (TIA), sponsored by AstraZeneca. Started May 2018; status: completed.
02
Drugs
ticagrelor
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on CTR20180172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180172.